Resources

1 Resources for

amylin

Subscribe to this listing via:
RSS
Email

Did you mean Amylin Pharmaceuticals Inc. (27 results)

BNET Resources

Directors Roster: a quarterly record of new director appointments: THE DIRECTORS & BOARDS Directors Roster--a quarterly record of new director appointments--is compiled from public and private sources by the editorial staff of DIRECTORS & BOARDS and is sponsored by Heidrick & Struggles. Please forward your directors' appointments to kmccarthy@directorsandboards.com. Submissions of new directors and appointments are welcome from...; Tags: Acorda Therapeutics Inc., Albemarle Corp., Alnylam Pharmaceuticals Inc., Amylin, board, career, Celanese Corp., chairman, Clayton Holdings Inc., Computer Associates International Inc., Cowen & Co., Deltic Timber Corp., DENTSPLY International Inc., director, Dominion Homes Inc., Ducommun Inc., Ecolab Inc., FactSet Research Systems Inc., FPL Group Inc., Gainsco Inc., Harte-Hanks Inc., Hartford Financial Services Group Inc., Healthways Inc., Kinetic Concepts Inc., LaBranche & Co. Inc., M., Mattson Technology Inc., president, revenue, Roster, United, Vertex Pharmaceuticals Inc.; Research articles 2007-03-22

Additional Resources

BioSeek Licenses Two Novel Anti-Inflammatory Peptides: BURLINGAME, Calif. -- BioSeek, Inc., a pioneer in the application of predictive human biology to drug discovery, announced today that it has exclusively licensed two novel anti-inflammatory peptides from Amylin Pharmaceuticals, Inc. The two novel peptides were identified as candidates for development by BioSeek as a result of an ongoing...; Articles 2008-11-13
Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference: SAN DIEGO, Nov. 13, 2008 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will be presenting at the Lazard Capital Markets Healthcare Conference in New York on Wednesday, November 19, 2008 at 8:30 a.m. ET. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will be providing a corporate...; Articles 2008-11-13
Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction: Changes will result in over $80 million reduction in 2009 cash expenditures SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced a corporate restructuring that will reduce its San Diego workforce by approximately 25 percent, or 340 employees, and reduce anticipated 2009 cash expenditures...; Articles 2008-11-10
HealthEd Wins Silver 2008 MM&M Award: CLARK, N.J. -- HealthEd, a leader in educational marketing solutions for healthcare companies, today announced that the agency and Amylin Pharmaceuticals, Inc., have won the prestigious 2008 MM&M Silver Award for Best Total Integration Program for Small Companies for the SYMLIN([R]) "Getting Somewhere" patient support program. Each year, the MM&M...; Articles 2008-11-06

Amylin Pharmaceuticals to Present at BIOCOM Investor Conference: SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will be presenting at the BIOCOM Investor Conference in San Diego on Tuesday, October 28, 2008 at 10:30 a.m. PT. Mark G. Foletta, Amylin's Senior Vice President of Finance and Chief Financial Officer, will be providing a corporate overview....; Articles 2008-10-23
Zacks Analyst Blog Highlights: Schlumberger Ltd., Amylin Pharmaceuticals, Inc., Eli Lilly & Co., Onyx Pharmaceuticals, Inc. and Diageo Plc: CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Schlumberger Ltd. (NYSE: SLB), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly...; Articles 2008-10-23
Amylin Pharmaceuticals Reports Third Quarter Financial Results: Product sales increased 14% over third quarter 2007 to $201 million SAN DIEGO, Oct. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today reported financial results for the quarter ended September 30, 2008. The Company reported total revenue of $218.4 million for the third quarter, including net...; Articles 2008-10-21
Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly: Lilly to Pay Amylin $125 Million and Extend $165 Million Line of Credit to Amylin SAN DIEGO and INDIANAPOLIS, Oct. 21 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced they have entered into a product supply agreement for exenatide once weekly,...; Articles 2008-10-21
Amylin Pharmaceuticals to Webcast Third Quarter Results: SAN DIEGO, Oct. 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. will Webcast its Quarterly Update Conference Call for the third quarter of 2008 on Tuesday, October 21, 2008 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury, Amylin's President and Chief Executive Officer, will lead the call. On the...; Articles 2008-10-15
Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: LPX, SHPGY, WNR, WIN, AMLN, STEC: DALLAS, Oct. 8 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Louisiana-Pacific Corp. , Shire Limited , Western Refining Inc. ,...; Articles 2008-10-08
Zacks Analyst Blog Highlights: Epicor Software Corp., Amylin Pharmaceuticals, Inc., CNOOC Ltd., Skyworks Solutions, Inc. and Nokia Corp: CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Epicor Software Corp. (Nasdaq: EPIC), Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), CNOOC...; Articles 2008-10-02
Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society: Data support the therapeutic potential of Amylin's integrated neurohormonal approach to obesity pharmacotherapy SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. today announced that new data for its pipeline obesity candidates will be presented at the 2008 Annual Scientific Meeting of The Obesity Society in...; Articles 2008-10-01
Manhattan Research lists top sites: TWO DIABETES product sites, Merck's Januvia and Takeda's Actos, came in first and second, respectively, in a new study measuring physicians' web habits. The study, conducted by Manhattan Research, ranked drug product sites based on visitation rates from physicians. Merck had the most products on the list, at three,...; Articles 2008-10-01
Corporate shaker Carl Icahn ups his ownership in Amylin: Billionaire activist investor Carl Icahn, known for shaking up the public firms he gains control of, raised his stake in Amylin Pharmaceuticals Inc. on Sept. 12. Icahn recently earned headlines as chairman of New York-based ImClone Systems Inc. for rejecting a $60-a-share offer by Bristol-Myers Squibb, then refusing to reveal...; Articles 2008-09-22
Biotechnology companies: ranked by number of local employees as of Aug. 1, 2008: BIOTECHNOLOGY COMPANIESRanked by number of local employees as of Aug. 1, 2008 ...; Articles 2008-09-22
First Reported Head-to-Head Study Showed BYETTA® Injection Provided Greater Reduction in Post-Meal Glucose Levels Than Januvia in Patients With Type 2 Diabetes: Patients Taking BYETTA Also Reduced Food Intake ROME, Sept. 9 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced results from a randomized, double-blind, cross-over, four-week head-to-head study demonstrating that BYETTAR exenatide injection, a GLP-1 receptor agonist, provided significantly lower glucose levels...; Articles 2008-09-09
Metabasis Therapeutics Appoints Dr. Molly Holman as Vice President of Intellectual Property: SAN DIEGO -- Metabasis Therapeutics, Inc. (Nasdaq:MBRX) announced today that Molly A. Holman, Ph.D., J.D. has joined the Company as Vice President of Intellectual Property. Dr. Holman has extensive scientific, legal and industry experience in the biotechnology and pharmaceutical fields. Dr. Holman was formerly at Amylin Pharmaceuticals from...; Articles 2008-09-09
Patient deaths noted: in a conference call, executives with Amylin Pharmaceuticals Inc. acknowledged four more deaths reported to the FDAbut not previously made publicassociated with the diabetes drug Byett: Patient Deaths Noted: In a conference call, executives with Amylin Pharmaceuticals Inc. acknowledged four more deaths reported to the FDA--but not previously made public--associated with the diabetes drug Byetta. The drug is co-marketed by San Diego-based Amylin and Eli Lilly and Co. of Indianapolis. The FDA...; Articles 2008-09-01
Zacks Analyst Blog Highlights: Sappi Ltd., Amylin Pharmaceuticals Inc., Eli Lilly and Co., Rudolph Technologies, Inc. and Tesoro Corp: CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sappi Ltd. (NYSE: SPP), Amylin Pharmaceuticals Inc. (Nasdaq: AMLN), Eli Lilly...; Articles 2008-08-28

<< Previous
page 1 of 1
Next >>

Resources

amylin

BNET Resources

Additional Resources

Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors